Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc H Scheetz

Showing results (121-130 of 222) with videos related to

Pageof 23
Sort By:
Pharmacy (Basel, Switzerland)|December 15, 2019
Implementation of an Extended-Infusion Piperacillin-Tazobactam Dosing Protocol: Unexpected Findings when Monitoring Safety and Compliance with Smart Pump TechnologyNathaniel J Rhodes, Jenna Lopez, Cecilia K Pham, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2026
Predictive accuracy of population meropenem models in critically ill pneumonia patientsAdrian Valadez, Emma Harlan, Colin Jeantet, et al.
Pharmacotherapy|May 26, 2018
Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis PatientsSean N Avedissian, Cristina Miglis, Christine J Kubin, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research NetworkNathaniel J Rhodes, Jamie L Wagner, Susan L Davis, et al.
International Journal of Antimicrobial Agents|April 14, 2020
Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitalsJamie L Wagner, Nathaniel J Rhodes, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
Evaluation of Dose-Fractionated Polymyxin B on Acute Kidney Injury Using a Translational <i>In Vivo</i> Rat ModelJiajun Liu, Gwendolyn M Pais, Sean N Avedissian, et al.
Diagnostic Microbiology and Infectious Disease|August 26, 2006
The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococciMarc H Scheetz, Chao Qi, Gary A Noskin, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Population Pharmacokinetics of Intravenous Polymyxin B from Clinical SamplesChristine J Kubin, Brian C Nelson, Cristina Miglis, et al.
Antimicrobial Agents and Chemotherapy|February 17, 2026
Elevated hippocampal and cortical cefepime concentrations correlate with seizures in an acute kidney injury rat modelGwendolyn M Pais, Emily Lesnicki, Sylwia Marianski, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Critical Need for Clarity in Polymyxin B DosingNikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
Pageof 23

Showing results (121-130 of 222) with videos related to

Sort By:
Pageof 23
Pharmacy (Basel, Switzerland)|December 15, 2019
Implementation of an Extended-Infusion Piperacillin-Tazobactam Dosing Protocol: Unexpected Findings when Monitoring Safety and Compliance with Smart Pump TechnologyNathaniel J Rhodes, Jenna Lopez, Cecilia K Pham, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2026
Predictive accuracy of population meropenem models in critically ill pneumonia patientsAdrian Valadez, Emma Harlan, Colin Jeantet, et al.
Pharmacotherapy|May 26, 2018
Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis PatientsSean N Avedissian, Cristina Miglis, Christine J Kubin, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research NetworkNathaniel J Rhodes, Jamie L Wagner, Susan L Davis, et al.
International Journal of Antimicrobial Agents|April 14, 2020
Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitalsJamie L Wagner, Nathaniel J Rhodes, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
Evaluation of Dose-Fractionated Polymyxin B on Acute Kidney Injury Using a Translational <i>In Vivo</i> Rat ModelJiajun Liu, Gwendolyn M Pais, Sean N Avedissian, et al.
Diagnostic Microbiology and Infectious Disease|August 26, 2006
The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococciMarc H Scheetz, Chao Qi, Gary A Noskin, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Population Pharmacokinetics of Intravenous Polymyxin B from Clinical SamplesChristine J Kubin, Brian C Nelson, Cristina Miglis, et al.
Antimicrobial Agents and Chemotherapy|February 17, 2026
Elevated hippocampal and cortical cefepime concentrations correlate with seizures in an acute kidney injury rat modelGwendolyn M Pais, Emily Lesnicki, Sylwia Marianski, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Critical Need for Clarity in Polymyxin B DosingNikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
Pageof 23